Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2016 | 1 |
2017 | 1 |
2018 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Citations
2
articles
found by citation matching
Detection of innate immune response modulating impurities in therapeutic proteins.
PLoS One. 2015.
PMID: 25901912
Free PMC article.
Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients.
Thacker SG, et al.
Front Immunol. 2022.
PMID: 36148237
Free PMC article.
Search results
Filters applied: . Clear all
Page 1
Detection of innate immune response modulating impurities (IIRMI) in therapeutic peptides and proteins: Impact of excipients.
Thacker SG, Her C, Kelley-Baker L, Ireland DDC, Manangeeswaran M, Pang ES, Verthelyi D.
Thacker SG, et al.
Front Immunol. 2022 Sep 6;13:970499. doi: 10.3389/fimmu.2022.970499. eCollection 2022.
Front Immunol. 2022.
PMID: 36148237
Free PMC article.
Product- and process- related impurities can act as adjuvants that activate the local or systemic innate immune response increasing the likelihood of product immunogenicity. Thus, assessing whether products have innate immune response …
Product- and process- related impurities can act as adjuvants that activate the local or systemic innate immune resp …
Item in Clipboard
Detection of innate immune response modulating impurities in therapeutic proteins.
Haile LA, Puig M, Kelley-Baker L, Verthelyi D.
Haile LA, et al.
PLoS One. 2015 Apr 22;10(4):e0125078. doi: 10.1371/journal.pone.0125078. eCollection 2015.
PLoS One. 2015.
PMID: 25901912
Free PMC article.
Currently, while products are tested for host cell protein content, assays to control innate immune response modulating impurities (IIRMIs) in products are focused mainly on endotoxin and nucleic acids, however, depending on the cell subs …
Currently, while products are tested for host cell protein content, assays to control innate immune response …
Item in Clipboard
In Vivo Effect of Innate Immune Response Modulating Impurities on the Skin Milieu Using a Macaque Model: Impact on Product Immunogenicity.
Haile LA, Puig M, Polumuri SK, Ascher J, Verthelyi D.
Haile LA, et al.
J Pharm Sci. 2017 Mar;106(3):751-760. doi: 10.1016/j.xphs.2016.11.001. Epub 2016 Dec 4.
J Pharm Sci. 2017.
PMID: 27923493
Unwanted immune responses to therapeutic proteins can severely impact their safety and efficacy. ...Here we used purified PRR agonists as model impurities to assess the minimal level of individual innate immune response modulati …
Unwanted immune responses to therapeutic proteins can severely impact their safety and efficacy. ...Here we used purifi …
Item in Clipboard
Aggregates of IVIG or Avastin, but not HSA, modify the response to model innate immune response modulating impurities.
Polumuri SK, Haile LA, Ireland DDC, Verthelyi D.
Polumuri SK, et al.
Sci Rep. 2018 Jul 31;8(1):11477. doi: 10.1038/s41598-018-29850-4.
Sci Rep. 2018.
PMID: 30065306
Free PMC article.
Therapeutic proteins can induce immune responses that affect their safety and efficacy. Product aggregates and innate immune response modulating impurities (IIRMI) are risk factors of product immunogenicity. ...
Therapeutic proteins can induce immune responses that affect their safety and efficacy. Product aggregates and innat …
Item in Clipboard
Cite
Cite